078972941	078972941	CD	B-NP	O
|	|	NNP	I-NP	O
CH	CH	NNP	I-NP	O
|	|	VBD	B-VP	O
45164443	45164443	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6697561	6697561	CD	B-NP	O
|	|	CC	I-NP	O
3/23/2003	3/23/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Renal	Renal	JJ	I-NP	I-protein
failure	failure	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/13/2003	10/13/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/18/2003	1/18/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
WOODMORE	WOODMORE	NN	B-NP	O
,	,	,	O	O
RYAN	RYAN	NN	B-NP	O
712-92-55-7	712-92-55-7	CD	I-NP	O
Fordauuxvan	Fordauuxvan	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
RNM	RNM	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
1/1/03	1/1/03	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MCCARTHY	MCCARTHY	NNP	B-NP	O
,	,	,	O	O
ELVIS	ELVIS	NNP	B-NP	O
RAYMOND	RAYMOND	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
PHOSLO	PHOSLO	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
ACETATE	ACETATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
334	334	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
CATAPRES	CATAPRES	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLONIDINE	CLONIDINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
0.3	0.3	CD	I-NP	O
MG/DAY	MG/DAY	NN	I-NP	O
TP	TP	NN	I-NP	O
Q168H	Q168H	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
ERYTHROPOIETIN	ERYTHROPOIETIN	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	O
EPOETIN	EPOETIN	NN	I-NP	O
ALFA	ALFA	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
4	4	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
3x/week	3x/week	NN	I-NP	O
LABETALOL	LABETALOL	NN	I-NP	O
HCL	HCL	NN	I-NP	O
600	600	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	B-VP	O
50	50	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Take	Take	VB	B-VP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

LISINOPRIL	LISINOPRIL	NN	B-NP	B-protein
40	40	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/17/03	1/17/03	CD	B-NP	O
by	by	IN	B-PP	O
HOLLIBAUGH	HOLLIBAUGH	NN	B-NP	O
,	,	,	O	O
HUMBERTO	HUMBERTO	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
08615965	08615965	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/17/03	1/17/03	CD	B-NP	O
by	by	IN	B-PP	O
SILVEY	SILVEY	NN	B-NP	O
,	,	,	O	O
HECTOR	HECTOR	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
98605301	98605301	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
PREDNISONE	PREDNISONE	NN	B-NP	B-DNA
10	10	CD	I-NP	I-DNA
MG	MG	NN	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
QOD	QOD	NN	I-NP	I-DNA
ZOCOR	ZOCOR	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
10	10	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/4/03	7/4/03	CD	B-NP	O
by	by	IN	B-PP	O
UTLEY	UTLEY	NN	B-NP	O
,	,	,	O	O
ANDRE	ANDRE	NN	B-NP	B-DNA
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
NEPHROCAPS	NEPHROCAPS	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
84827778	84827778	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
FK506	FK506	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
TACROLIMUS	TACROLIMUS	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q12H	Q12H	NN	I-NP	O
X	X	NN	I-NP	O
60	60	CD	I-NP	O
Days	Days	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Separate	Separate	JJ	I-NP	O
antacids	antacid	NNS	I-NP	O
by	by	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
two	two	CD	I-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
avoid	avoid	VB	B-VP	O
grapefruit	grapefruit	NN	B-NP	B-protein
juice	juice	NN	I-NP	I-protein
NEPHROCAPS	NEPHROCAPS	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
NEPHRO-VIT	NEPHRO-VIT	NN	I-NP	I-protein
RX	RX	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/4/03	7/4/03	CD	B-NP	O
by	by	IN	B-PP	O
BIRCH	BIRCH	NNP	B-NP	O
,	,	,	O	O
BOYD	BOYD	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
NIFEDIPINE	NIFEDIPINE	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SUSTAINED	SUSTAINED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NIFEDIPINE	NIFEDIPINE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S.	S.	NNP	I-NP	O
.	.	.	O	O
.	.	''	O	O
-RRB-	-RRB-	.	O	B-protein

30	30	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

DOXERCALCIFEROL	DOXERCALCIFEROL	NN	B-NP	O
2.5	2.5	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
RENAGEL	RENAGEL	NNP	I-NP	O
800	800	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
please	please	VB	B-INTJ	O
give	give	VB	B-VP	O
only	only	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

thanks	thank	NNS	B-NP	O
.	.	.	O	O

KEFLEX	KEFLEX	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	I-NP	O
CEPHALEXIN	CEPHALEXIN	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
X	X	SYM	B-NP	O
7	7	CD	I-NP	O
Days	Day	NNS	I-NP	O
FLEXERIL	FLEXERIL	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
CYCLOBENZAPRINE	CYCLOBENZAPRINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
COLCHICINE	COLCHICINE	NN	I-NP	O
0.6	0.6	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QOD	QOD	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/day	cals/day	NN	I-NP	O
/	/	SYM	B-NP	O
Renal	Renal	JJ	I-NP	B-protein
diet	diet	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FDI	FDI	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
ACTIVITY	ACTIVITY	NNP	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Kidney	Kidney	NNP	B-NP	O
Doctor	Doctor	NNP	I-NP	O
-	-	HYPH	O	O
Dr.	Dr.	NNP	B-NP	O
Rattanasinh	Rattanasinh	NNP	I-NP	O
,	,	,	O	O
February	February	NNP	B-NP	O
at	at	IN	B-PP	O
8	8	CD	B-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
am	am	NN	I-NP	O
4/4/03	4/4/03	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dialysis	Dialysis	NN	B-NP	O
at	at	IN	B-PP	O
Seh	Seh	NNP	B-NP	O
Quillei	Quillei	NNP	I-NP	O
Rehabilitation	Rehabilitation	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Thurs	Thurs	NNP	I-NP	O
10/28	10/28	CD	I-NP	O
at	at	IN	B-PP	O
11	11	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
am	am	NN	I-NP	O
,	,	,	O	O
No	No	NNP	B-NP	O
Known	Known	NNP	I-NP	O
Allergies	Allergies	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
end	end	VB	B-VP	O
stage	stage	NN	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Renal	Renal	NNP	I-NP	O
failure	failure	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
dm	dm	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
depression	depression	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
depression	depression	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
left	leave	VBD	B-VP	O
total	total	JJ	B-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
PATIENT	PATIENT	NN	B-NP	O
IDENTIFICATION	IDENTIFICATION	NN	I-NP	O
:	:	:	O	O
50	50	CD	B-NP	O
yo	yo	NN	I-NP	O
male	male	JJ	I-NP	O
s/p	s/p	NN	I-NP	O
renal	renal	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
presents	present	NNS	I-NP	O
will	will	MD	B-VP	O
acute	acute	VB	I-VP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
50	50	CD	B-NP	O
yo	yo	NN	I-NP	O
male	male	JJ	B-ADJP	O
with	with	IN	B-PP	O
ESRD	ESRD	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
from	from	IN	B-PP	O
94-99	94-99	CD	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
cadaveric	cadaveric	JJ	I-NP	O
renal	renal	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
in	in	IN	B-PP	O
5/22	5/22	CD	B-NP	O
Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
few	few	JJ	I-NP	O
yrs	yr	NNS	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-VP	O
Cr	Cr	NNP	B-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
in	in	IN	B-PP	O
2001	2001	CD	B-NP	O
,	,	,	O	O
7	7	CD	B-NP	O
in	in	IN	B-PP	O
2002	2002	CD	B-NP	O
,	,	,	I-NP	O
8	8	CD	I-NP	O
in	in	IN	B-PP	O
early	early	JJ	B-NP	O
February	February	NNP	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
year	year	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
USOH	USOH	NN	I-NP	B-protein
until	until	IN	B-PP	O
1	1	CD	B-NP	O
wk	wk	NN	I-NP	O
ago	ago	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	B-protein
developed	develop	VBD	B-VP	I-protein
R	R	NN	B-NP	I-protein
axilla	axilla	NN	I-NP	I-protein
infection	infection	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hidradenitis	hidradenitis	NN	I-NP	I-protein
suppurativa	suppurativa	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
+	+	SYM	O	O
DOE	DOE	NNP	B-NP	O
.	.	.	O	O

Seen	Seen	NN	B-NP	O
in	in	IN	B-PP	O
urgent	urgent	JJ	B-NP	O
care	care	NN	I-NP	O
10/18	10/18	CD	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
keflex	keflex	NN	B-NP	O
.	.	.	O	O

Seen	Seen	NN	B-NP	O
in	in	IN	B-PP	O
renal	renal	JJ	B-NP	O
clinic	clinic	NN	I-NP	O
1/27	1/27	CD	I-NP	O
and	and	CC	O	O
labs	lab	NNS	B-NP	O
revealed	reveal	VBD	B-VP	O
:	:	:	O	O
Cr	Cr	NN	B-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
6	6	CD	I-NP	O
,	,	,	O	O
k	k	NN	B-NP	O
6.8	6.8	CD	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
then	then	RB	B-ADVP	O
sent	send	VBD	B-VP	O
to	to	TO	B-PP	O
ED	ED	NNP	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
etiology	etiology	NN	I-NP	O
was	be	VBD	B-VP	O
unclear	unclear	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
FK	FK	NN	I-NP	B-protein
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
4.8	4.8	CD	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
UA	UA	NNP	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
urine	urine	NN	B-NP	O
eos	eo	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
low	low	JJ	I-NP	O
bicarb	bicarb	NN	I-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	B-DNA
underlying	underlie	VBG	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
non-complaince	non-complaince	JJ	I-NP	O
with	with	IN	B-PP	O
taking	take	VBG	B-VP	O
his	his	PRP$	B-NP	O
bicarb	bicarb	NN	I-NP	O
replacement	replacement	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
D5W	D5W	NN	B-NP	B-protein
+	+	SYM	B-NP	O
3	3	CD	I-NP	O
amps	amp	NNS	I-NP	O
HCO3	HCO3	NN	I-NP	B-protein
and	and	CC	O	O
was	be	VBD	B-VP	O
ultimately	ultimately	RB	I-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
dialysis	dialysis	NN	B-NP	O
6/11	6/11	CD	I-NP	O
due	due	JJ	B-ADVP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
bicarb	bicarb	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
per	per	IN	B-PP	O
renal	renal	JJ	B-VP	O
his	his	PRP$	B-NP	O
immunosupressive	immunosupressive	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
cellcept	cellcept	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
prednisone	prednisone	NN	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
qod	qod	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
FK	FK	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
from	from	IN	B-PP	O
2	2	CD	B-NP	O
to	to	TO	I-NP	O
1mg	1mg	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
to	to	TO	I-VP	O
end	end	VB	I-VP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patients	patient	NNS	I-NP	O
K	K	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADVP	O
at	at	IN	B-PP	O
6.8	6.8	CD	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
decreased	decrease	VBD	B-VP	O
with	with	IN	B-PP	O
kayexalate	kayexalate	NN	B-NP	O
and	and	CC	I-NP	O
dialysis	dialysis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
iPTH	iPTH	NN	I-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
and	and	CC	I-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
399	399	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
dialysis	dialysis	NN	B-NP	O
upopn	upopn	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
renally	renally	RB	B-NP	O
dosed	dose	VBN	I-NP	O
ancef	ancef	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
axilla	axilla	NN	I-NP	O
skin	skin	NN	I-NP	O
infection	infection	NN	I-NP	O
which	which	WDT	B-NP	O
improved	improve	VBD	B-VP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-cell_line
blood	blood	NN	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
finish	finish	VB	I-VP	O
a	a	DT	B-NP	O
7	7	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
keflex	keflex	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
ankle	ankle	NN	I-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
8/2	8/2	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
plain	plain	JJ	I-NP	O
film	film	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

PULM	PULM	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
incidental	incidental	JJ	I-NP	O
finding	finding	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
nodule	nodule	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
CXR	CXR	NN	I-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
CT	CT	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
just	just	RB	B-ADVP	O
his	his	PRP$	B-NP	O
first	first	JJ	I-NP	O
right	right	JJ	I-NP	O
costo-chondrojunction	costo-chondrojunction	NN	I-NP	O
with	with	IN	B-PP	O
osteophytes	osteophyte	NNS	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Return	Return	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
or	or	CC	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
concern	concern	NN	I-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
kidney	kidney	NN	I-NP	O
doctor	doctor	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Doorley	Doorley	NNP	I-NP	O
Follow	Follow	NNP	I-NP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
arm	arm	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
KUBA	KUBA	NNP	B-NP	O
,	,	,	O	O
CAREY	CAREY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
VA32	VA32	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/1/03	1/1/03	CD	I-NP	O
@	@	HYPH	B-NP	O
12	12	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

